Xylem Reports Second Quarter 2024 Results and Raises Full-Year Guidance

Rhea-AI Summary

Xylem Inc. (NYSE: XYL) reported strong second-quarter 2024 results, with revenue of $2.2 billion, up 26% on a reported basis and 9% organically. Earnings per share rose 78% to $0.80, or $1.09 on an adjusted basis, up 11%. The company raised its full-year guidance, now expecting revenue of $8.55 billion, a 16% increase, with organic growth of 5-6%. Adjusted EPS guidance was increased to $4.18-$4.28.

Net income reached $194 million, with a margin increase of 360 basis points to 8.9%. Adjusted EBITDA margin expanded 170 basis points to 20.8%. The company cited healthy demand, disciplined operational execution, and progress on Evoqua integration and synergies as key drivers of performance.

Positive

• Revenue increased 26% to $2.2 billion, with 9% organic growth
• Earnings per share grew 78% to $0.80, adjusted EPS up 11% to $1.09
• Net income margin expanded 360 basis points to 8.9%
• Adjusted EBITDA margin improved 170 basis points to 20.8%
• Full-year revenue guidance raised to $8.55 billion, up 16%
• Adjusted EPS guidance increased to $4.18-$4.28
• Free cash flow conversion guidance raised to at least 120%

Negative

• Orders declined 1% organically despite 12% reported growth
• Potential macro variability expected in the second half of the year

Financial Analyst

Xylem's Q2 2024 results demonstrate robust financial performance and positive momentum. The company reported $2.2 billion in revenue, a substantial 26% increase on a reported basis and 9% organically. This growth outpaces many industry peers and indicates strong market positioning.

Earnings per share saw a remarkable 78% increase to $0.80 on a reported basis and 11% growth to $1.09 on an adjusted basis. The adjusted EBITDA margin expanded by 170 basis points to 20.8%, reflecting operational efficiency and effective cost management.

Particularly noteworthy is Xylem's decision to raise its full-year guidance. The new revenue target of $8.55 billion represents a 16% year-over-year increase, up from the previous 15-16% range. The organic growth projection of 5-6% suggests confidence in core business performance.

The increased adjusted EPS guidance of $4.18 to $4.28 indicates management's optimism about profitability. The raised free cash flow conversion target of at least 120% of net income is a strong indicator of the company's ability to generate cash from its operations.

While orders grew 12% on a reported basis, the 1% organic decline warrants attention. This could signal potential headwinds in certain markets or segments, which investors should monitor in future quarters.

Market Research Analyst

Xylem's Q2 results and raised guidance reflect resilience in the water technology sector. The company's 9% organic revenue growth suggests strong underlying demand for water management solutions, likely driven by increasing global water challenges and infrastructure needs.

The integration of Evoqua, mentioned as "well on track," is a key strategic move. This acquisition expands Xylem's portfolio and market reach, potentially contributing to the raised guidance. Investors should watch for synergy realization and integration progress in coming quarters.

Xylem's diverse portfolio of "mission-critical solutions" positions it well to capitalize on intensifying water challenges globally. This diversification may provide resilience against potential macroeconomic variability in the second half of the year.

The 1% organic decline in orders, despite overall growth, could indicate uneven demand across different geographic regions or product segments. It's important to monitor whether this trend persists and how it might impact future quarters.

The water technology market appears to have strong tailwinds, with Xylem's performance suggesting sustained demand for water infrastructure and management solutions. However, investors should remain vigilant about potential macroeconomic headwinds and their impact on public and private sector spending in this space.

• Revenue of $2.2 billion, up 26% on a reported basis and 9% organically
• Earnings per share of $0.80, up 78%; $1.09 on an adjusted basis, up 11%
• Raising full-year revenue guidance to $8.55 billion, up approximately 16%, with organic revenue growth of 5% to 6%, up from 4% to 6%
• Increasing full-year adjusted EPS guidance to $4.18 to $4.28, from $4.10 to $4.25

WASHINGTON--(BUSINESS WIRE)-- Xylem Inc. (NYSE: XYL), a leading global water technology company that empowers customers and communities to build a more water-secure world, today reported second-quarter results. The Company’s total revenue was $2.2 billion on strong execution and demand, and second-quarter earnings per share were up 78 percent on a reported basis and 11 percent on an adjusted basis, exceeding Xylem’s previous guidance. Orders grew 12 percent on a reported basis and declined 1 percent organically.

“The team continued to build on Xylem’s momentum and outperformed expectations on all metrics in the second quarter,” said Xylem’s President and CEO, Matthew Pine. “Healthy demand, combined with the team’s disciplined operational execution, delivered significant margin expansion in the quarter. Evoqua integration and synergies are also well on track.”

“We are further raising our full-year revenue, margin and earnings guidance. We are confident in the team’s commitment to realizing our operational potential, and underlying demand in our largest markets remains resilient despite likely macro variability in the second half. Our diversified portfolio of mission-critical solutions is ideally positioned to meet global demand from intensifying water challenges.”

Net income was $194 million, or $0.80 per share. Net income margin increased 360 basis points to 8.9 percent. These results are driven by strong operational performance, partially offset by higher purchase accounting intangible amortization. Adjusted net income was $266 million, or $1.09 per share, which excludes the impacts of restructuring and realignment costs, amortization of acquired intangible assets, gain/loss from sale of businesses, special charges, and tax-related special items.

Second-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 20.8 percent, reflecting a year-over-year increase of 170 basis points. Productivity savings, volume, and price drove the margin expansion, exceeding the impact of inflation, strategic investments and mix.

Outlook

Xylem now expects full-year 2024 revenue of $8.55 billion, up approximately 16 percent on a reported basis and up approximately 5 to 6 percent on an organic basis. This represents an increase from the Company’s previous full-year guidance of 15 to 16 percent on a reported basis and 4 to 6 percent on an organic basis.

Full-year 2024 adjusted EBITDA margin is expected to be approximately 20.5 percent, increased from the previous guide of 20.0 percent. This results in adjusted earnings per share of $4.18 to $4.28, raised from the previous range of $4.10 to $4.25. Full-year free cash flow conversion to net income is expected to be at least 120 percent, an increase compared to the prior guidance of 115 percent.

Further 2024 planning assumptions are included in Xylem’s second-quarter earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Supplemental information on Xylem’s second-quarter earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to solving the world’s critical water challenges with innovation and expertise. Our 23,000 diverse employees delivered combined pro forma revenue of $8.1 billion in 2023. We are creating a more sustainable world by enabling our customers to optimize water and resource management and helping communities in more than 150 countries become water-secure. Join us at www.xylem.com and Let’s Solve Water.

Forward-Looking Statements

This press release contains “forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, interest rates, inflation and related monetary policy by governments in response to inflation, and the strength of the residential and commercial real estate markets, on economic activity and our operations; geopolitical events, including the ongoing and possible escalation of the conflicts involving Russia and Ukraine, and the Middle East, as well as regulatory, economic and other risks associated with our global sales and operations, including those related to domestic content requirements applicable to projects receiving governmental funding; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, tight labor markets, prevailing price changes, tariffs and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents or other disruptions of information technology systems on which we rely, or involving our connected products and services; lack of availability or delays in receiving parts and raw materials from our supply chain, including electronic components (in particular, semiconductors); disruptions in operations at our facilities or that of third parties upon which we rely; uncertainty related to the realization of the benefits and synergies from our acquisition of Evoqua Water Technologies Corp.; safe and compliant treatment and handling of water, wastewater and hazardous materials; failure to successfully execute large projects, including with respect to meeting performance guarantees and customers’ budgets, timelines and safety requirements; our ability to retain and attract leadership and other diverse and key talent, as well as competition for overall talent and labor; defects, security, warranty and liability claims, and recalls related to our products; uncertainty around restructuring and realignment actions and related costs and savings; our ability to execute strategic investments for growth, including related to acquisitions and divestitures; availability, regulation or interference with radio spectrum used by certain of our products; volatility in served markets or impacts on our business and operations due to weather conditions, including the effects of climate change; risks related to our sustainability commitments and related disclosures; fluctuations in foreign currency exchange rates; difficulty predicting our financial results; risk of future impairments to goodwill and other intangible assets; changes in our effective tax rates or tax expenses; financial market risks related to our pension and other defined benefit plans; failure to comply with, or changes in, laws or regulations, including those pertaining to our business conduct, operations, products and services, including anti-corruption, data privacy and security, trade, competition, the environment, climate change and health and safety; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; matters related to intellectual property infringement or expiration of rights; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 ("2023 Annual Report") and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).

Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors, to our business, operating results, financial condition, outlook, or strategy, to our impacts on sustainability matters or other parties, or are required to be disclosed in our filings with the SEC. In addition, historical, current, and forward-looking social, environmental and sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

XYLEM INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited) (in millions, except per share data)
	Three Months						Six Months
For the periods ended June 30,		2024			2023			2024				2023
Revenue from products	$	1,802		$	1,501		$	3,492			$	2,809
Revenue from services		367			221			710				361
Revenue		2,169			1,722			4,202				3,170
Cost of revenue from products		1,079			916			2,100				1,707
Cost of revenue from services		271			155			531				266
Cost of revenue		1,350			1,071			2,631				1,973
Gross profit		819			651			1,571				1,197
Selling, general and administrative expenses		485			446			959				800
Research and development expenses		58			58			117				111
Restructuring and asset impairment charges		23			28			33				36
Operating income		253			119			462				250
Interest expense		11			12			25				21
Other non-operating income, net		4			7			10				11
Gain/(Loss) on sale of businesses		1			—			(4	)			—
Income before taxes		247			114			443				240
Income tax expense		53			22			96				49
Net income	$	194		$	92		$	347			$	191
Earnings per share:
Basic	$	0.80		$	0.45		$	1.43			$	0.99
Diluted	$	0.80		$	0.45		$	1.43			$	0.98
Weighted average number of shares:
Basic		242.6			205.5			242.2				193.0
Diluted		243.5			206.7			243.3				194.0

XYLEM INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (in millions, except per share amounts)
	June 30, 2024				December 31, 2023
ASSETS
Current assets:
Cash and cash equivalents	$	815			$	1,019
Receivables, less allowances for discounts, returns and credit losses of $54 and $56 in 2024 and 2023, respectively		1,675				1,617
Inventories		1,057				1,018
Prepaid and other current assets		234				230
Total current assets		3,781				3,884
Property, plant and equipment, net		1,144				1,169
Goodwill		7,509				7,587
Other intangible assets, net		2,374				2,529
Other non-current assets		957				943
Total assets	$	15,765			$	16,112
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	940			$	968
Accrued and other current liabilities		1,085				1,221
Short-term borrowings and current maturities of long-term debt		17				16
Total current liabilities		2,042				2,205
Long-term debt		1,981				2,268
Accrued post-retirement benefits		325				344
Deferred income tax liabilities		552				557
Other non-current accrued liabilities		517				562
Total liabilities		5,417				5,936
Stockholders’ equity:
Common stock – par value $0.01 per share:
Authorized 750.0 shares, issued 259.1 shares and 257.6 shares in 2024 and 2023, respectively		3				3
Capital in excess of par value		8,660				8,564
Retained earnings		2,774				2,601
Treasury stock – at cost 16.2 shares and 16.0 shares in 2024 and 2023, respectively		(751	)			(733	)
Accumulated other comprehensive loss		(345	)			(269	)
Total stockholders’ equity		10,341				10,166
Non-controlling interests		7				10
Total equity		10,348				10,176
Total liabilities and stockholders’ equity	$	15,765			$	16,112

XYLEM INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions)
For the six months ended June 30,		2024				2023
Operating Activities
Net income	$	347			$	191
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		123				69
Amortization		156				83
Share-based compensation		31				27
Restructuring and asset impairment charges		33				36
Loss from sale of business		4				—
Other, net		(4	)			(5	)
Payments for restructuring		(18	)			(9	)
Changes in assets and liabilities (net of acquisitions):
Changes in receivables		(84	)			(122	)
Changes in inventories		(75	)			(57	)
Changes in accounts payable		(2	)			36
Changes in accrued and deferred taxes		(14	)			(86	)
Other, net		(120	)			(154	)
Net Cash – Operating activities		377				9
Investing Activities
Capital expenditures		(147	)			(103	)
Acquisitions of businesses, net of cash acquired		(5	)			(476	)
Proceeds from sale of business		11				91
Proceeds from the sale of property, plant and equipment		3				—
Cash received from investments		4				—
Cash paid for investments		(7	)			—
Cash paid for equity investments		(2	)			(56	)
Cash received from interest rate swaps		—				38
Cash received from cross-currency swaps		14				14
Other, net		1				3
Net Cash – Investing activities		(128	)			(489	)
Financing Activities
Short-term debt issued, net		—				74
Short-term debt repaid		(268	)			—
Long-term debt issued, net		—				275
Long-term debt repaid		(9	)			(1	)
Repurchase of common stock		(18	)			(9	)
Proceeds from exercise of employee stock options		63				40
Dividends paid		(175	)			(139	)
Other, net		(12	)			(5	)
Net Cash – Financing activities		(419	)			235
Effect of exchange rate changes on cash		(34	)			9
Net change in cash and cash equivalents		(204	)			(236	)
Cash and cash equivalents at beginning of year		1,019				944
Cash and cash equivalents at end of period	$	815			$	708
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest	$	36			$	30
Income taxes (net of refunds received)	$	110			$	135

Xylem Inc. Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures that we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.

“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.

“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.

"Adjusted EBITDA Margin" and "Adjusted Segment EBITDA Margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.

"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, amortization of acquired intangible assets, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.

"Adjusted Operating Margin" and "Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.

“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures, and "Free Cash Flow Conversion" defined as Free Cash Flows divided by net income, excluding the gain on sale of businesses and other non-recurring, significant non-cash impacts, such as non-cash impairment charges and significant deferred tax items. Our definitions of "free cash flow" and "free cash flow conversion" do not consider certain non-discretionary cash payments, such as debt.

"Adjusted Free Cash Flow" defined as free cash flow adjusted for significant cash items for which the corresponding income statement impact does not occur within the same fiscal year.

“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

“Special charges" defined as non-recurring costs incurred by the Company, such those related to acquisitions and integrations, divestitures and non-cash impairment charges.

“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic and Constant Currency Orders ($ Millions)
	(As Reported - GAAP)													(As Adjusted - Organic)												Constant Currency
			(A)		(B)									(C)			(D)			(E) = B+C+D			(F) = E/A			(G) = (E - C) / A
					Change			% Change						Acquisitions / Divestitures						Change			% Change
	Orders		Orders		2024 v. 2023			2024 v. 2023			Book-to-Bill						FX Impact			Adj. 2024 v. 2023			Adj. 2024 v. 2023
	2024		2023
Six Months Ended June 30
Xylem Inc.	4,333		3,426		907			26	%		103	%		(886	)		10			31			1	%		27	%
Water Infrastructure	1,336		1,024		312			30	%		111	%		(243	)		3			72			7	%		31	%
Applied Water	945		928		17			2	%		106	%		-			3			20			2	%		2	%
Measurement and Control Solutions	813		885		(72	)		(8	%)		86	%		-			1			(71	)		(8	%)		(8	%)
Water Solutions and Services	1,239		589		650			110	%		107	%		(643	)		3			10			2	%		111	%
Quarter Ended June 30
Xylem Inc.	2,087		1,856		231			12	%		96	%		(265	)		11			(23	)		(1	%)		13	%
Water Infrastructure	690		563		127			23	%		109	%		(89	)		5			43			8	%		23	%
Applied Water	465		445		20			4	%		102	%		-			3			23			5	%		5	%
Measurement and Control Solutions	384		470		(86	)		(18	%)		80	%		-			1			(85	)		(18	%)		(18	%)
Water Solutions and Services	548		378		170			45	%		91	%		(176	)		2			(4	)		(1	%)		46	%
Quarter Ended March 31
Xylem Inc.	2,246		1,570		676			43	%		110	%		(621	)		(1	)		54			3	%		43	%
Water Infrastructure	646		461		185			40	%		113	%		(154	)		(2	)		29			6	%		40	%
Applied Water	480		483		(3	)		(1	%)		110	%		-			-			(3	)		(1	%)		(1	%)
Measurement and Control Solutions	429		415		14			3	%		93	%		-			-			14			3	%		3	%
Water Solutions and Services	691		211		480			227	%		123	%		(467	)		1			14			7	%		228	%

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic and Constant Currency Revenue ($ Millions)
	(As Reported - GAAP)										(As Adjusted - Organic)												Constant Currency
			(A)		(B)						(C)			(D)			(E) = B+C+D			(F) = E/A			(G) = (E - C) / A
					Change			% Change			Acquisitions / Divestitures						Change			% Change
	Revenue		Revenue		2024 v. 2023			2024 v. 2023						FX Impact			Adj. 2024 v. 2023			Adj. 2024 v. 2023
	2024		2023
Six Months Ended June 30
Xylem Inc.	4,202		3,170		1,032			33	%		(782	)		11			261			8	%		33	%
Water Infrastructure	1,205		929		276			30	%		(221	)		5			60			6	%		30	%
Applied Water	892		931		(39	)		(4	%)		-			3			(36	)		(4	%)		(4	%)
Measurement and Control Solutions	944		762		182			24	%		-			1			183			24	%		24	%
Water Solutions and Services	1,161		548		613			112	%		(561	)		2			54			10	%		112	%
Quarter Ended June 30
Xylem Inc.	2,169		1,722		447			26	%		(302	)		13			158			9	%		27	%
Water Infrastructure	631		519		112			22	%		(84	)		6			34			7	%		23	%
Applied Water	456		478		(22	)		(5	%)		-			4			(18	)		(4	%)		(4	%)
Measurement and Control Solutions	482		384		98			26	%		-			2			100			26	%		26	%
Water Solutions and Services	600		341		259			76	%		(218	)		1			42			12	%		76	%
Quarter Ended March 31
Xylem Inc.	2,033		1,448		585			40	%		(480	)		(2	)		103			7	%		40	%
Water Infrastructure	574		410		164			40	%		(137	)		(1	)		26			6	%		40	%
Applied Water	436		453		(17	)		(4	%)		-			(1	)		(18	)		(4	%)		(4	%)
Measurement and Control Solutions	462		378		84			22	%		-			(1	)		83			22	%		22	%
Water Solutions and Services	561		207		354			171	%		(343	)		1			12			6	%		171	%

Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
	Q2 2024											Q2 2023
	As Reported			Adjustments				Adjusted				As Reported			Adjustments				Adjusted
Total Revenue		2,169			-				2,169				1,722			-				1,722
Operating Income		253			99		a		352				119			140		a		259
Operating Margin		11.7	%						16.2	%			6.9	%						15.0	%
Interest Expense		(11	)		-				(11	)			(12	)		-				(12	)
Other Non-Operating Income (Expense)		4			-				4				7			-				7
Gain/(Loss) From Sale of Business		1			(1	)	b		-				-			-				-
Income before Taxes		247			98				345				114			140				254
Provision for Income Taxes		(53	)		(26	)	c		(79	)			(22	)		(30	)	c		(52	)
Net Income		194			72				266				92			110				202
Diluted Shares		243.5							243.5				206.7							206.7
Diluted EPS		$0.80			$0.29				$1.09				$0.45			$0.53				$0.98

a	Quarter-to-date:
	Restructuring & realignment costs: 2024 - $29 million and 2023 - $37 million
	Special charges: 2024 - $11 million of acquisition & integration cost and $2 million of other special charges; 2023 - $61 million of acquisition & integration related costs and $6 million of other special charges
	Purchase accounting intangible amortization: 2024 - $57 million and 2023 - $36 million
c	Quarter-to-date: 2024 - Net tax impact on pre-tax adjustments (note a and b) of $20 million and other tax special items of $6 million; 2023 - Net tax impact on pre-tax adjustments (note a) of $30 million

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
2024
		Q1			Q2			Q3			Q4			Total
Net Income		153			194									347
Net Income margin		7.5	%		8.9	%								8.3	%
Depreciation		61			62									123
Amortization		73			83									156
Interest Expense (Income), net		7			6									13
Income Tax Expense		43			53									96
EBITDA		337			398			-			-			735
Share-based Compensation		18			13									31
Restructuring & Realignment		15			29									44
Special Charges		16			13									29
Loss/(Gain) from sale of business		5			(1	)								4
Adjusted EBITDA		391			452			-			-			843
Revenue		2,033			2,169									4,202
Adjusted EBITDA Margin		19.2	%		20.8	%								20.1	%
Year over Year Expansion		290bps			170bps
2023
		Q1			Q2			Q3			Q4			Total
Net Income		99			92			152			266			609
Net Income margin		6.8	%		5.3	%		7.3	%		12.6	%		8.3	%
Depreciation		28			41			63			61			193
Amortization		32			51			84			76			243
Interest Expense (Income), net		2			5			6			8			21
Income Tax Expense		27			22			33			(56	)		26
EBITDA		188			211			338			355			1,092
Share-based Compensation		12			15			18			15			60
Restructuring & Realignment		11			36			33			23			103
U.K. Pension Settlement		-			-			-			-			-
Special Charges		25			67			22			22			136
Loss/(Gain) from sale of business		-			-			-			1			1
Adjusted EBITDA		236			329			411			416			1,392
Revenue		1,448			1,722			2,076			2,118			7,364
Adjusted EBITDA Margin		16.3	%		19.1	%		19.8	%		19.6	%		18.9	%

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240729341575/en/

Media

Houston Spencer +1 (914) 240-3046

houston.spencer@xylem.com

Investors

Andrea van der Berg +1 (914) 260-8612

andrea.vanderberg@xylem.com

Source: Xylem Inc.

FAQ

What was Xylem's (XYL) revenue in Q2 2024?

Xylem's revenue in Q2 2024 was $2.2 billion, up 26% on a reported basis and 9% organically.

How much did Xylem's (XYL) earnings per share increase in Q2 2024?

Xylem's earnings per share increased 78% to $0.80 on a reported basis, and 11% to $1.09 on an adjusted basis in Q2 2024.

What is Xylem's (XYL) updated full-year 2024 revenue guidance?

Xylem raised its full-year 2024 revenue guidance to $8.55 billion, representing approximately 16% growth on a reported basis and 5-6% organic growth.

What is Xylem's (XYL) new adjusted EPS guidance for 2024?

Xylem increased its adjusted EPS guidance for 2024 to a range of $4.18 to $4.28, up from the previous range of $4.10 to $4.25.

How did Xylem's (XYL) adjusted EBITDA margin perform in Q2 2024?

Xylem's adjusted EBITDA margin in Q2 2024 was 20.8%, reflecting a year-over-year increase of 170 basis points.